Ask a Patient® Health News: Drugs & Treatments
Subscribe
Sign in
Home
Notes
Drug Safety Updates
Special Features
Archive
About
Latest
Top
Discussions
November 2024 Drug Safety Updates Part 4: Cancer Drugs: Ayvakit, Keytruda, Oxaliplatin, more
Ayvakit (avapritinib) tablets
Dec 1
•
Katie Rowley
Share this post
Ask a Patient® Health News: Drugs & Treatments
November 2024 Drug Safety Updates Part 4: Cancer Drugs: Ayvakit, Keytruda, Oxaliplatin, more
Copy link
Facebook
Email
Notes
More
Pulmonary Aspiration Warning for GLP-1 (Glucagon-like peptide-1) Diabetes and Weight Loss Meds
GLP-1 medications help patients lose weight by delaying the movement of food from the stomach into the small intestine, suppressing appetite.
Dec 1
Share this post
Ask a Patient® Health News: Drugs & Treatments
Pulmonary Aspiration Warning for GLP-1 (Glucagon-like peptide-1) Diabetes and Weight Loss Meds
Copy link
Facebook
Email
Notes
More
November 2024
November 2024 Drug Safety Updates Part 3: Brilinta's interaction with rosuvastatin; Caduet; 3 HIV drugs; ILARIS for autoinflammatory…
Consumer-friendly summaries of new safety information added to Food and Drug Administration (FDA) drug labels
Nov 18
•
Katie Rowley
Share this post
Ask a Patient® Health News: Drugs & Treatments
November 2024 Drug Safety Updates Part 3: Brilinta's interaction with rosuvastatin; Caduet; 3 HIV drugs; ILARIS for autoinflammatory disease; Spravato for treatment-resistant depression
Copy link
Facebook
Email
Notes
More
New Brain-Administered Gene Therapy; New drugs for: UTIs, Hemophilia, Stomach Cancer, Breast Cancer
Gene Therapy Stimulates Brain’s Dopamine Production
Nov 17
2
Share this post
Ask a Patient® Health News: Drugs & Treatments
New Brain-Administered Gene Therapy; New drugs for: UTIs, Hemophilia, Stomach Cancer, Breast Cancer
Copy link
Facebook
Email
Notes
More
Recommended Articles and Podcasts on Drugs & Treatments: November 2024
Herbal medicine, independent pharmacy dilemmas, FDA and AI-powered treatments, manufacturing quality, HRT, TV drug advertising changes, insulin pens…
Nov 17
Share this post
Ask a Patient® Health News: Drugs & Treatments
Recommended Articles and Podcasts on Drugs & Treatments: November 2024
Copy link
Facebook
Email
Notes
More
November 2024 Drug Safety Update Part 2: Meds for Prostate Cancer; Leukemia; Hereditary Angioedema; Acute Radiation Syndrome; Heparin Meds
Consumer-friendly summaries of new safety information added to Food and Drug Administration (FDA) drug labels
Nov 10
•
Katie Rowley
Share this post
Ask a Patient® Health News: Drugs & Treatments
November 2024 Drug Safety Update Part 2: Meds for Prostate Cancer; Leukemia; Hereditary Angioedema; Acute Radiation Syndrome; Heparin Meds
Copy link
Facebook
Email
Notes
More
Phenylephrine-containing OTC oral decongestants on the FDA chopping block; No mention of Rx versions
On November 7, 2024, the FDA announced its proposal to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) medications.
Nov 10
•
Katie Rowley
1
Share this post
Ask a Patient® Health News: Drugs & Treatments
Phenylephrine-containing OTC oral decongestants on the FDA chopping block; No mention of Rx versions
Copy link
Facebook
Email
Notes
More
November 2024 Drug Safety Update Part 1: Botox Cosmetic and Dry Eye, Cardio Effects; Antifungals; Briumvi for MS; Biosimilars for Prolia and…
Consumer-friendly summaries of new safety information added to Food and Drug Administration (FDA) drug labels
Nov 3
•
Katie Rowley
4
Share this post
Ask a Patient® Health News: Drugs & Treatments
November 2024 Drug Safety Update Part 1: Botox Cosmetic and Dry Eye, Cardio Effects; Antifungals; Briumvi for MS; Biosimilars for Prolia and Stelara; Limbitrol Antidepressant; GLP-1 Meds
Copy link
Facebook
Email
Notes
More
1
October 2024
October 2024 Drug Safety Update Part 2: Skin Conditions, Eye disease, Leukemia, Lung, Malaria, Overactive Bladder, Type 2, and Tuberculosis…
Consumer-friendly summaries of new safety information added to FDA drug labels
Oct 20
•
Katie Rowley
1
Share this post
Ask a Patient® Health News: Drugs & Treatments
October 2024 Drug Safety Update Part 2: Skin Conditions, Eye disease, Leukemia, Lung, Malaria, Overactive Bladder, Type 2, and Tuberculosis treatments
Copy link
Facebook
Email
Notes
More
October 8, 2024: Promising schizophrenia drug approved; tirzepatide (Mounjaro and Zepbound) no longer in shortage; real-world performance of…
New Drug Approvals: Cobenfy for Schizophrenia
Oct 8
1
Share this post
Ask a Patient® Health News: Drugs & Treatments
October 8, 2024: Promising schizophrenia drug approved; tirzepatide (Mounjaro and Zepbound) no longer in shortage; real-world performance of Ozempic; breast cancer podcast; healthy tips
Copy link
Facebook
Email
Notes
More
October 2024 Drug Safety Update Part 1: Sickle cell drug withdrawn; Quviviq, Aldara, Xeljanz, Dupixent and cancer drugs; breast feeding and…
Consumer-friendly summaries of new safety information added to FDA drug labels
Oct 6
•
Katie Rowley
1
Share this post
Ask a Patient® Health News: Drugs & Treatments
October 2024 Drug Safety Update Part 1: Sickle cell drug withdrawn; Quviviq, Aldara, Xeljanz, Dupixent and cancer drugs; breast feeding and meds
Copy link
Facebook
Email
Notes
More
September 2024
September 22, 2024: new drugs for MS, eczema; first-ever treatment for rare and devastating Niemann Pick childhood disease; non-drug capsule…
New Drug Approvals
Sep 22
Share this post
Ask a Patient® Health News: Drugs & Treatments
September 22, 2024: new drugs for MS, eczema; first-ever treatment for rare and devastating Niemann Pick childhood disease; non-drug capsule for weight loss; Neuralink nod; med tips and more
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts